Filtros de búsqueda

Lista de obras de Susan M Domchek

A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors

artículo científico publicado en 2017

A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer

artículo científico publicado en 2016

A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

article

A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity

artículo científico publicado en 2012

A counseling framework for moderate-penetrance colorectal cancer susceptibility genes.

artículo científico publicado en 2018

A functionally significant SNP in TP53 and breast cancer risk in African-American women

artículo científico publicado en 2017

A genome-wide association study of breast cancer in women of African ancestry

artículo científico publicado en 2012

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

artículo científico publicado en 2010

A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

artículo científico publicado en 2012

A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale

artículo científico publicado en 2016

AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study

artículo científico publicado en 2007

Abstract 1291: High and moderate penetrance germline mutations in a number of genes are responsible for a small proportion of familial breast cancer risk in BRCAx families

article

Abstract P2-11-04: Education and information preferences for women with triple-negative breast cancer: Should personal or medical demographic variables impact program tailoring?

Abstract P5-17-06: Emotional/psychological characteristics of women with triple-negative breast cancer: Do socioeconomic, demographic, and provider variables impact emotional change from diagnosis to post-treatment?

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

article

Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patients

artículo científico publicado en 2013

Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.

artículo científico publicado en 2015

An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2016

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

artículo científico publicado en 2015

Antimüllerian hormone levels are lower in BRCA2 mutation carriers

artículo científico publicado en 2017

Application of breast cancer risk prediction models in clinical practice

artículo científico publicado en 2003

Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study

artículo científico publicado en 2013

Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer

artículo científico publicado en 2017

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

artículo científico publicado en 2015

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

artículo científico publicado en 2016

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

artículo científico publicado en 2010

Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography

artículo científico publicado en 2015

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

artículo científico publicado en 2017

BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk

scientific article published on August 2012

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

artículo científico publicado en 2015

BRIP1 as an ovarian cancer susceptibility gene: ready for the clinic?

artículo científico publicado en 2015

Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac Dysfunction

artículo científico publicado en 2016

Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer

artículo científico publicado en 2012

Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.

artículo científico publicado en 2007

Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2006

Breast Cancer Predisposition Syndromes ⬇️

artículo científico publicado el 1 de octubre de 2010

Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy

artículo científico publicado en 2015

Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers

artículo científico publicado en 2012

Breast cancer gene variants: separating the harmful from the harmless

artículo científico publicado en 2009

Breast cancer in young women

artículo científico publicado en 2010

Breast cancer risk among male BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2007

Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

artículo científico publicado en 2012

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

artículo científico publicado en 2016

Breast-Cancer Risk in Families With Mutations in PALB2

Breast-cancer risk in families with mutations in PALB2

artículo científico publicado en 2014

CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients

artículo científico publicado en 2012

CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment

artículo científico publicado en 2014

Cancer susceptibility mutations in individuals with breast and ovarian cancer using next-generation sequencing

Cancer treatment according to BRCA1 and BRCA2 mutations

artículo científico publicado en 2012

Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study

artículo científico publicado en 2007

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma

artículo científico publicado en 2003

Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons FromBRCA1/2-Associated Breast Cancer

article

Clinical Management of Hereditary Breast Cancer Syndromes ⬇️

artículo científico publicado el 1 de marzo de 2011

Clinical implications of low-penetrance breast cancer susceptibility alleles

artículo científico publicado en 2009

Clinically relevant changes in family history of cancer over time

artículo científico publicado en 2011

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2011

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction

artículo científico publicado en 2010

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

artículo científico publicado en 2011

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2008

Common genetic variants and modification of penetrance of BRCA2-associated breast cancer

artículo científico publicado en 2010

Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers

artículo científico publicado en 2011

Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

artículo científico publicado en 2012

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

scientific article published on 05 August 2009

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

artículo científico publicado en 2011

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing

artículo científico publicado en 2016

Contraceptive use and the role of contraceptive counseling in reproductive-aged women with cancer

artículo científico publicado en 2014

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

scholarly article by Mia M Gaudet published in November 2010

Counselling framework for moderate-penetrance cancer-susceptibility mutations

artículo científico publicado en 2016

DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3.

artículo científico publicado en 2015

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Differential lysis of tumors by polyclonal T cell lines and T cell clones specific for hTERT.

artículo científico publicado en 2007

Dose-response effects of aerobic exercise on estrogen among women at high risk for breast cancer: a randomized controlled trial

artículo científico publicado en 2015

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials

artículo científico publicado en 2017

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

article by Timothy R. Rebbeck et al published November 2005 in Journal of Clinical Oncology

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

artículo científico publicado en 2012

Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

artículo científico publicado en 2015

Erratum to: Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers

artículo científico publicado en 2015

Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

artículo científico publicado en 2017

Ethical Implications of Direct-to-Consumer Hereditary Cancer Tests

artículo científico publicado en 2018

Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry

artículo científico publicado en 2012

Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer

artículo científico publicado en 2016

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2017

Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis

artículo científico publicado en 2010

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

artículo científico publicado en 2010

Exercise-Induced Dose-Response Alterations in Adiponectin and Leptin Levels Are Dependent on Body Fat Changes in Women at Risk for Breast Cancer

artículo científico publicado en 2016

Exploring the link between MORF4L1 and risk of breast cancer

artículo científico publicado en 2011

Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations

artículo científico publicado en 2008

Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers

artículo científico publicado en 2013

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2016

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

article

Follow-up frequency and compliance in women with probably benign findings on breast magnetic resonance imaging

artículo científico

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

artículo científico publicado en 2016

Gemcitabine and trastuzumab combinations for patients with metastatic breast cancer overexpressing HER2/neu

artículo científico publicado en 2004

Gene-panel sequencing and the prediction of breast-cancer risk

artículo científico publicado en 2015

Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry

artículo científico publicado en 2012

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers

artículo científico publicado en 2011

Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer

artículo científico publicado en 2016

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

artículo científico publicado en 2013

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2011

Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer

scientific article published on 09 May 2016

Homeostasis of peripheral FoxP3(+) CD4 (+) regulatory T cells in patients with early and late stage breast cancer

article

How genetic variant libraries effectively extend gene testing patents: implications for intellectual property and good clinical care

artículo científico publicado en 2012

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

artículo científico publicado en 2017

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk

artículo científico publicado en 2013

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

artículo científico publicado en 2016

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

artículo científico publicado en 2016

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

artículo científico publicado en 2015

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

artículo científico publicado en 2017

Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision Oncology Workshop

artículo científico publicado en 2017

Immunotherapy for Breast Cancer: What Are We Missing?

artículo científico publicado en 2017

Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women

artículo científico publicado en 2013

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

artículo científico publicado en 2016

Inherited mutations in breast cancer patients with and without multiple primary cancers

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2008

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

artículo científico publicado en 2011

Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry

artículo científico publicado en 2011

Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status

artículo científico publicado en 2011

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

artículo científico publicado en 2010

Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?

artículo científico publicado en 2011

Long-term risk of medical conditions associated with breast cancer treatment

artículo científico publicado en 2014

Low rates of African American participation in genetic counseling and testing for BRCA1/2 mutations: racial disparities or just a difference?

artículo científico publicado en 2012

Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer.

artículo científico publicado en 2006

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.

artículo científico publicado en 2016

Medical oncologists' willingness to participate in bundled payment programs.

artículo científico publicado en 2018

Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors

artículo científico publicado en 2013

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

artículo científico publicado en 2009

Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes

artículo científico publicado en 2011

Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers

artículo científico publicado en 2009

Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis

artículo científico publicado en 2014

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

artículo científico publicado en 2006

Multidisciplinary meeting on male breast cancer: summary and research recommendations

artículo científico publicado en 2010

Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del

artículo científico publicado en 2009

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

Multiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?

Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencing

artículo científico publicado en 2014

Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations

artículo científico publicado en 2018

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

artículo científico publicado en 2015

No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2008

No evidence that GATA3 rs570613 SNP modifies breast cancer risk

scientific article published on 11 December 2008

Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction

artículo científico publicado en 2016

Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers

artículo científico publicado en 2010

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

artículo científico publicado en 2017

Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer.

artículo científico publicado en 2017

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation

artículo científico publicado en 2014

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

PALB2 mutations in familial breast and pancreatic cancer

artículo científico publicado en 2011

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

artículo científico publicado en 2011

Patients' resistance to risk information in genetic counseling for BRCA1/2.

artículo científico publicado en 2005

Physical and psychological health in rare cancer survivors

artículo científico publicado en 2016

Population Frequency of Germline BRCA1/2 Mutations.

artículo científico publicado en 2016

Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study

artículo científico publicado en 2010

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

artículo científico publicado en 2017

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group

artículo científico publicado en 2008

Proceedings of the 8th Annual Conference on the Science of Dissemination and Implementation : Washington, DC, USA. 14-15 December 2015

article by David Chambers et al published 1 August 2016 in Implementation Science

Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.

artículo científico publicado en 2009

Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.

artículo científico publicado en 2008

Prophylactic oophorectomy in women at increased cancer risk

artículo científico publicado en 2007

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

artículo científico publicado en 2018

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

artículo científico publicado en 2018

Quality of life in long-term survivors of metastatic breast cancer

artículo científico publicado en 2012

Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers

artículo científico publicado en 2015

RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies

artículo científico publicado en 2007

RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

artículo científico publicado en 2015

Rapid progression of prostate cancer in men with a BRCA2 mutation

artículo científico publicado en 2008

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

artículo científico publicado en 2014

Refining Breast Cancer Risk Stratification: Additional Genes, Additional Information

artículo científico publicado en 2016

Reply to R.L. Nussbaum et al and J.S. Dolinsky et al.

artículo científico publicado en 2017

Reproductive Decision-Making in Women with BRCA1/2 Mutations

artículo científico publicado en 2016

Response: Table 1

article by Amanda B. Spurdle et al published 31 August 2016 in Journal of the National Cancer Institute

Retention of African American women in cancer genetics research.

artículo científico publicado en 2008

Reversion Mutations with Clinical Use of PARP Inhibitors: Many Genes, Many Versions

artículo científico publicado en 2017

Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2011

Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer

artículo científico publicado en 2012

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study

artículo científico publicado en 2008

Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men.

artículo científico publicado en 2013

Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women

artículo científico publicado en 2006

Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.

artículo científico publicado en 2006

Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update

artículo científico publicado en 2008

Stumbling blocks on the path to personalized medicine in breast cancer: the case of PARP inhibitors for BRCA1/2-associated cancers

artículo científico

Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers

artículo científico publicado en 2009

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study

artículo científico publicado en 2014

Telomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients.

artículo científico publicado en 2005

The clinical management of BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2008

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

artículo científico publicado en 2017

The prevention of hereditary breast cancer

artículo científico publicado en 2007

The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families

scientific article published on 14 August 2008

The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms

artículo científico publicado en 2015

The utility of ductal lavage in breast cancer detection and risk assessment

artículo científico publicado en 2002

Therapeutic approaches for women predisposed to breast cancer

artículo científico publicado en 2011

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach

artículo científico publicado en 2017

Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells

artículo científico publicado en 2010

Understanding participation by African Americans in cancer genetics research

scientific article published on July 2012

Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Use of systemic hormone therapy in BRCA mutation carriers

artículo científico publicado en 2016

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations

artículo científico publicado en 2016

Utilization of religious coping strategies among African American women at increased risk for hereditary breast and ovarian cancer

artículo científico publicado en 2009

Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes

artículo científico publicado en 2004

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

artículo científico publicado en 2011

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2008

Women In Steady Exercise Research (WISER) Sister: study design and methods

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda